Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Biological Effective Radiation Dose for Multiple Myeloma Palliation.
Journal: Advances in radiation oncology
Published: December 13, 2022
Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy.
Journal: Bone marrow transplantation
Published: April 21, 2022
ASTRO's Framework for Radiopharmaceutical Therapy Curriculum Development for Trainees.
Journal: International journal of radiation oncology, biology, physics
Published: November 15, 2021
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.
Journal: American journal of hematology
Published: April 20, 2021
Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: June 16, 2020
Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant.
Journal: Bone marrow transplantation
Published: March 05, 2018
Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.
Journal: American journal of clinical oncology
Published: December 02, 2016
A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases.
Journal: Advances in radiation oncology
Published: January 09, 2016
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 07, 2015
Dose escalation and dosimetry of first-in-human α radioimmunotherapy with 212Pb-TCMC-trastuzumab.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 27, 2014
Pazopanib combined with radiation: in vivo model of interaction.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: June 20, 2014
Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: November 16, 2013
Last Updated: 09/26/2026